MSB 5.50% $1.38 mesoblast limited

Coming News ???, page-191

  1. 212 Posts.
    lightbulb Created with Sketch. 23
    Most likely White House will release a report showing a study with various therapeutics used ranging from the initial ones such as steroids, then plasma/antibodies then finally stem cells. They will show the death rate being significantly reduced.

    the whole biotech sector will rise with specific companies rising more than others, it will then be up to the FDA to approve individual products over the coming months.

    it’s looking good for all stem cell companies especially mesoblast as we are leading the field
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.